About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Nr3c2tm1Gsc
targeted mutation 1, Gunther Schutz
MGI:2441654
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Nr3c2tm1Gsc/Nr3c2tm1Gsc involves: 129P2/OlaHsd * C57BL/6 MGI:3041700
ht2
Nr3c2tm1Gsc/Nr3c2+ involves: 129P2/OlaHsd * C57BL/6 MGI:3041780


Genotype
MGI:3041700
hm1
Allelic
Composition
Nr3c2tm1Gsc/Nr3c2tm1Gsc
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr3c2tm1Gsc mutation (0 available); any Nr3c2 mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Histological and immunocytochemical kidney analysis of Nr3c2tm1Gsc/Nr3c2tm1Gsc mice

mortality/aging
• all homozygotes died between postnatal days P8 and P13, on average at P10
• daily injection of betamethasone (a synthetic glucocorticoid), from P5 extended survival to ~17 days; however, betamethasone-treated homozygotes failed to thrive and eventually died

growth/size/body
• homozygotes displayed weight loss prior to death; however, reduced weight gain was not attributed to growth inhibition

hematopoietic system
• at P8, the hematocrit was increased from 32% in wild-type to 44%, indicating severe dehydration

homeostasis/metabolism
• plasma angiotensin II levels were increased 50-fold at P8
• plasma aldosterone levels were increased 65-fold at P8
• plasma renin concentration was normal at P0 but increased 8-fold at P4
• plasma renin levels were increased 440-fold at P8
• at P8, homozygotes were severely dehydrated
• amiloride-sensitive epithelial Na+ channel (ENaC)-mediated Na+ reabsorption was reduced to 24% in the kidney and to 16% in the colon
• homozygotes displayed hyperkalemia at P8
• homozygotes displayed hyponatremia at P8
• at P8, homozygotes displayed impaired distal tubular Na+ reabsorption relative to wild-type controls
• homozygotes displayed impaired amiloride-sensitive Na+ reabsorption, leading to changes similar to pseudohypoaldosteronism type 1
• amiloride-sensitive epithelial Na+ channel (ENaC)-mediated Na+ reabsorption was reduced to 24% in the kidney
• at P8, homozygotes showed a significant increase in urine Na+ (35.4 +/- 3.3 mmol/l) relative to wild-type controls (9.1 +/- 1.2 mmol/l)
• at P8, homozygotes exhibited a strong activation of the renin-angiotensin-aldosterone system, with a 440-fold increase in plasma renin levels, a 50-fold increase in plasma angiotensin II levels, and a 65-fold increase in plasma aldosterone levels relative to wild-type controls
• renin activity in the vascular pole region and along the entire afferent arteriole was highly increased along with the rise in plasma renin levels

renal/urinary system
N
• homozygotes displayed a normal glomerular filtration rate relative to wild-type controls
• at P8, homozygotes showed a significant increase in urine Na+ (35.4 +/- 3.3 mmol/l) relative to wild-type controls (9.1 +/- 1.2 mmol/l)
• at P8, the macula densa segment of the distal tubule appeared enlarged
• at P8, the extraglomerular mesangium showed significant hyperplasia
• at P8, renin-producing granular cells extended upstream along the afferent arteriole
• at P8, renin granules were detected in nearly all extraglomerular mesangium cells
• signs of changes at the glomerular vascular pole were first observed at P4
• at P8, the extraglomerular mesangium showed significant hyperplasia
• at P8, renin granules were detected in nearly all extraglomerular mesangium cells
• at P8, renin-producing granular cells extended upstream along the afferent arteriole
• at P8, the macula densa segment of the distal tubule appeared enlarged
• at P8, homozygotes displayed morphological changes at the glomerular vascular pole
• homozygotes showed an 8-fold increase in fractional excretion of Na+ leading to hypovolemia
• however, after amiloride injection, homozygotes displayed a lower increase in the fractional excretion of Na+ (from 2.7 to 4.5%) than wild-type (0.3 to 8%) and heterozygous (0.9 to 8.5%) controls
• at P8, homozygotes displayed impaired distal tubular Na+ reabsorption relative to wild-type controls
• homozygotes displayed impaired amiloride-sensitive Na+ reabsorption, leading to changes similar to pseudohypoaldosteronism type 1
• amiloride-sensitive epithelial Na+ channel (ENaC)-mediated Na+ reabsorption was reduced to 24% in the kidney

cardiovascular system
• homozygotes showed an 8-fold increase in fractional excretion of Na+ leading to hypovolemia

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
autosomal dominant pseudohypoaldosteronism type 1 DOID:0060855 OMIM:177735
J:77285




Genotype
MGI:3041780
ht2
Allelic
Composition
Nr3c2tm1Gsc/Nr3c2+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nr3c2tm1Gsc mutation (0 available); any Nr3c2 mutation (53 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
homeostasis/metabolism
• at P8, heterozygotes showed a ~3-fold increase in plasma angiotensin II levels relative to wild-type controls
• at P8, heterozygotes showed a 3-fold increase in plasma aldosterone levels relative to wild-type controls
• at P8, heterozygotes showed a 3.5-fold increase in plasma renin concentration relative to wild-type controls
• at P8, heterozygotes showed a significant increase in urine Na+ (19.6 +/- 2.5 mmol/l) relative to wild-type controls (9.1 +/- 1.2 mmol/l)
• at P8, heterozygotes exhibited a moderate activation of the renin-angiotensin-aldosterone system with a ~3-fold increase in plasma renin, aldosterone and angiotensin II levels relative to wild-type controls

renal/urinary system
• at P8, heterozygotes showed a significant increase in urine Na+ (19.6 +/- 2.5 mmol/l) relative to wild-type controls (9.1 +/- 1.2 mmol/l)
• at P8, heterozygotes showed a 3-fold increase in fractional excretion of Na+ relative to wild-type controls
• however, after amiloride injection, heterozygotes displayed a lower increase in the fractional excretion of Na+ (from 0.9 to 8.5%) than wild-type controls (0.3 to 8%)





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/19/2024
MGI 6.24
The Jackson Laboratory